Genprex, Inc. Gains 51.52%
Tue, May 05, 2020 at 05:30 PM
Genprex, Inc. (GNPX:NASDAQ) rocketted at $3.5, a gain of 51.5%. The stock got featured on our News Catalysts scanner on Tue 21 Apr 20 at 11:57 AM in the 'BIOTECH' category. From Mon 20 Apr 20, the stock recorded 50.00% Up Days and 45.45% Green Days
The share price of the company has been moving sideways in recent weeks.
About Genprex, Inc. (GNPX:NASDAQ)
Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.
Top 10 Gainers:
- Portola Pharmaceuticals, Inc. (PTLA:NASDAQ), 130.03%
- Ritter Pharmaceuticals, Inc. (RTTR:NASDAQ), 87.68%
- Genprex, Inc. (GNPX:NASDAQ), 51.52%
- DropCar, Inc. (DCAR:NASDAQ), 49.08%
- BioPharmX Corporation (BPMX:NYSEMKT), 39.43%
- Staffing 360 Solutions, Inc. (STAF:NASDAQ), 38.89%
- Adverum Biotechnologies, Inc. (ADVM:NASDAQ), 38.35%
- Conatus Pharmaceuticals Inc. (CNAT:NASDAQ), 38.27%
- Akebia Therapeutics, Inc. (AKBA:NASDAQ), 37.99%
- Lightbridge Corporation (LTBR:NASDAQ), 37.78%